Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Results of efficacy and pharmacokinetic studies of an anxiolytic prodrug

Aug. 24, 2004

New modafinil formulation shows promise for children with ADHD

Aug. 24, 2004

Endo acquires North American rights to Rapinyl

Aug. 24, 2004

New 5-HT6 antagonist with improved pharmacokinetic properties designed at GSK

Aug. 24, 2004

Menarini reports a new class of NK2 antagonists with potential as analgesic agents

Aug. 24, 2004

Novel NMDA antagonists may protect neurons from ischemia-induced cell death

Aug. 24, 2004

Abbott presents results of a neuronal nicotinic receptor agonist with analgesic activity

Aug. 23, 2004

SBIR grant supports development of improved interferon beta analogues

Aug. 23, 2004

Dual NK1 antagonists/5-HT reuptake inhibitors presented by AstraZeneca

Aug. 23, 2004

Two series of histamine H3 antagonists/inverse agonists designed at GSK

Aug. 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...